Publication | Closed Access

Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells

Nuclear MedicineEngineeringMedicineTheranosticsRadiochemical InvestigationsRadiopharmaceutical TherapyTumor TargetingAnti-cancer AgentVitro/in Vivo AssessmentPharmacologyRadiation OncologyTumor Microenvironment